Clinical Trial Update: Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating PK, safety, and efficacy of recombinant von Willebrand factor for treating bleeding episodes in von Willebrand disease has completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Willebrand Disease

Drugs mentioned

• recombinant von Willebrand factor (recombinant von Willebrand factor)

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Von Willebrand Disease | Phase 3 | Status: COMPLETED | Results posted: 2016-04-21